| Literature DB >> 30765409 |
Karen M Oude Hengel1,2, Pieter Coenen3, Suzan J W Robroek1, Cecile R L Boot3, Allard J van der Beek3, Frank J Van Lenthe1,4, Alex Burdorf1.
Abstract
INTRODUCTION: Obesity and unhealthy behaviour are more prevalent among workers with a low compared with a high socioeconomic position (SEP), and thus contribute to socioeconomic health inequalities. The occupational setting is considered an important setting to address unhealthy behaviours due to the possibility to efficiently reach a large group of adults through worksite health promotion. This paper describes the rationale and design for an individual participant data (IPD) meta-analysis and a socioeconomic equity-specific reanalysis aiming to: (1) investigate socioeconomic differences in the effectiveness of interventions aimed at promoting healthy behaviour and preventing obesity, (2) examine socioeconomic differences in reach and compliance and (3) to investigate underlying factors affecting possible socioeconomic differences. METHODS AND ANALYSIS: A systematic search was conducted in electronic databases including Embase, Medline Ovid, Web of Science, Cochrane Central and Google Scholar as well as in grey literature and trial registries. Two researchers have independently selected a total of 34 relevant studies (from 88 articles). Responsible researchers of these eligible studies were asked to provide their study data and an assessment of the methodological criteria was done. The data of the intervention studies will be pooled for the IPD meta-analysis, whereas the socioeconomic equity-specific reanalysis will focus on each study separately, stratified for SEP. Both methods will be conducted to investigate socioeconomic differences in effectiveness, reach and compliance (research aims 1 and 2). For research aim 3, different factors, such as population characteristics, organisational work environment and intervention characteristics, will be investigated as possible moderators in the associations between SEP and effectiveness, reach and compliance. ETHICS AND DISSEMINATION: The Medical Ethical Committee of Erasmus MC declared that the Medical Research Involving Human Subjects Act does not apply to the meta-analyses. The findings will be disseminated through peer-reviewed publications and (inter)national conference presentations. TRIAL REGISTRATION NUMBER: CRD42018099878. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: health promotion; obesity; occupational setting; socioeconomic inequalities; unhealthy behaviour
Mesh:
Year: 2019 PMID: 30765409 PMCID: PMC6398771 DOI: 10.1136/bmjopen-2018-025463
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow chart of study selection.
Methodological quality criteria
| Description | |
| A. Randomisation procedure | Positive if there was a clear description of the randomisation procedure and if the randomisation was adequately performed (ie, by a random selection of numbers or by a computer-generated list). |
| B. Blinding of participants | Positive if the participant was unaware of being assigned to the intervention group or control group |
| C. Similarity of groups | Positive if baseline characteristics of the comparison groups were comparable OR if there were important differences in potential confounders but these appropriately adjusted for in the analysis. |
| D. Compliance | Positive if participants attended the intervention satisfactorily according to the opinion of the reviewers |
| E. Loss to follow-up | Positive if the percentage of dropouts during the study period did not exceed 20% for short-term follow-up (=3 months) OR 30% for long-term follow-up (>3 months) |
| F. Intention-to-treat | Positive if an intention-to-treat analysis was performed for the outcome variable |
| G. Controlled for confounders | Positive if the analysis was controlled for potential confounders |
| H. Data collection method | Positive if data collection tools shown to be credible (eg, shown to be valid and reliable in published research, OR in a pilot study, OR taken from a published national survey, OR recognised as an acceptable measure (such as biochemical measures of smoking)). |
| I. Follow-up | Positive if follow-up was at least 6 months |